https://doi.org/10.1016/j.biomaterials.2020.119857 Our unified experimental and computational approach provided underlying insights needed to guide potential therapies for Alport syndrome (AS) that ameliorate the adverse effects from AS disease onset and progression. Patients with AS exhibit blood and elevated protein levels in their urine, inflamed kidneys, and many other abnormalities.
Recent comments